BioStock article: Aptahem approaching milestone via oversubscribed rights issue
2020-11-26
BioStock published an article on 26 November 2020 about Aptahem, which can be read in full below. Biotechnology company Aptahem, that develops its drug candidate Apta-1 for the treatment of life-threatening organ and tissue damage caused by sepsis, was...
Read More